Comparison of the Phoenix automated system, the Etest method and broth microdilution in determining temocillin susceptibility of Enterobacteriaceae

Journal of Antimicrobial Chemotherapy

Volumn 68, Issue 7, 2013, Pages 1685-1686

  Patel, Trupti A ^a   Dilley, Rachel ^a   Williams, Alan ^a   Vanstone, Gemma L ^a   Balakrishnan, Indran ^a  

^a ROYAL FREE LONDON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Antimicrobial resistance; Extended spectrum lactamases; Gram negative bacteria

Indexed keywords

BETA LACTAMASE AMPC; EXTENDED SPECTRUM BETA LACTAMASE; TEMOCILLIN;

ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIUM ISOLATE; BROTH DILUTION; CITROBACTER; CITROBACTER BRAAKII; CITROBACTER FARMERI; CITROBACTER FREUNDII; CITROBACTER KOSERI; COMPUTER PROGRAM; ENTEROBACTER AEROGENES; ENTEROBACTER CLOACAE; ENTEROBACTERIACEAE; ESCHERICHIA COLI; ETEST METHOD; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA PNEUMONIAE; KLUYVERA; MICROBIOLOGICAL PARAMETERS; MINIMUM INHIBITORY CONCENTRATION; MORGANELLA MORGANII; PANTOEA AGGLOMERANS; PROTEUS MIRABILIS; PROTEUS VULGARIS; PROVIDENCIA RETTGERI; RAOULTELLA ORNITHINOLYTICA; SERRATIA LIQUEFACIENS; SERRATIA MARCESCENS;

EID: 84879476740     PISSN: 03057453     EISSN: 14602091     Source Type: Journal    
DOI: 10.1093/jac/dkt049     Document Type: Article

References (4)

1. Gupta ND, Smith RE, Balakrishnan I. Clinical efficacy of temocillin. J Antimicrob Chemother 2009; 64: 431-3.
2. Balakrishnan I, Awad-El-Kariem FM, Aali A et al. Temocillin use in England: clinical and microbiological efficacies in infections caused by extended-spectrum and/or derepressed AmpC b-lactamase-producing Enterobacteriaceae. J Antimicrob Chemother 2011; 66: 2628-31.
3. Andrews JM, Jevons G, Walker R et al. Temocillin susceptibility by BSAC methodology. J Antimicrob Chemother 2007; 60: 185-7.
4. Rodriguez-Villalobos H, Cardentey-Reyes A, Thiroux C et al. Comparison of four commercial methods for determining temocillin susceptibility of Escherichia coli. J Antimicrob Chemother 2009; 63: 832-4.